Sprinklr (CXM) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended October 2025 Sprinklr reported revenue of $219.07 million, up 9.2% year-over-year, and EPS of $0.12 (vs $0.10 a year ago), beating Zacks consensus revenue ($209.55M) by 4.54% and EPS ($0.09) by 33.33%. Subscription revenue was $190.3M (+5.4% YoY) with subscription gross margin at 76% (slightly below the 76.5% estimate) while professional services revenue rose to $28.77M (+43.5% YoY); the stock has returned +2.9% over the past month and carries a Zacks Rank #2 (Buy).

Analysis

Market structure: Sprinklr's beat (revenue $219.1M, +9.2% YoY; subscription $190.3M, +5.4%; services +43.5%) benefits CXM platform demand and services/consulting vendors while putting mild pressure on legacy ticketing players that lack analytics/omnichannel features. The services surge signals stronger near-term implementation demand but reduces operating leverage — a 50bp miss vs. est. gross margin (76% vs 76.5%) implies limited immediate pricing power and potential mix shift from recurring subscription to lower-margin services.

Risk assessment: Near-term tail risks include macro-driven enterprise IT spend cuts, a material large-customer churn (>5% of ARR) and margin erosion if services remain >12% of revenue; these are low-probability but high-impact for valuation. Timeline: expect IV/price compression in days post-earnings, guidance-driven volatility in the next 30–90 days, and subscription/margin re-rating over 3–12 months. Key hidden dependency: renewal cadence and concentration of top-20 customers; watch any single customer >3–5% ARR.

Trade implications: Tactical long bias on CXM (small-cap SaaS with positive execution) but size it — start 2–3% portfolio position, add to 5% if subscription growth accelerates to >8–10% YoY next quarter or gross margin expands +200bps. Options: consider a 3-month 30-delta call or vertical call spread to limit premium risk and sell near-term calls after IV settles. Pair trade: long CXM vs short a broader ticketing/legacy-CRM name (e.g., ZEN or smaller legacy peers) to isolate CX/analytics outperformance.

Contrarian angles: Consensus likley underweights that services spike may be one-off from large roll-outs; if next quarter services normalize and subscription re-accelerates, CXM could be underpriced — upside >30% in 6–12 months. Conversely, market may be underpricing the risk that persistent services mix reduces long-term gross margins below 74%, which would justify a 15–25% downside. Historical parallel: several mid-cap SaaS stocks that leaned on services saw multiple compression until ARR growth recovered, so watch ARR cadence closely.

Key Decisions for Investors

• Establish an initial 2–3% long position in CXM within 3 trading days post-release; add to 5% if next quarter subscription revenue growth >8% YoY or gross margin improves by ≥200bps.
• Buy a 3-month 30-delta CXM call (or equivalent vertical call spread to cap cost) sized to 0.5–1% of portfolio; sell a near-term covered call after IV normalizes to finance carry if up >10% in 10 trading days.
• Initiate a pair trade: long CXM (2% exposure) / short ZEN (or another legacy ticketing/CRM name, 2% exposure) to capture CX analytics outperformance; cut pair if CXM underperforms by 15% or subscription growth falls below 5% YoY.
• Trim broader SaaS exposure by 1–2% and rotate into high-quality enterprise SaaS names (CXM, CRM, ADBE) if macro spending signals remain stable; reduce exposure immediately if CIO spend survey or public guidance indicates >10% cut in IT budgets within 60 days.
• Set hard risk thresholds to protect capital: stop-loss at 15% downside on CXM positions, and liquidate/add hedge if professional services remain >15% of revenue or gross margin falls below 74% in next two quarters.